IN8bio Announces Third Quarter 2024 Financial Results and Corporate Highlights

IN8bio Reports 100% of AML Patients in Remission at EHA Congress INB-100 Trial Success IN8bio, Inc. has made a groundbreaking announcement at the 2024 European Hematology Association (EHA) Congress, reporting that 100% of Acute Myeloid Leukemia (AML) patients treated with their INB-100 therapy remain in complete remission (CR). This remarkable achievement is a significant milestone…

Read More

“Goldman Sachs CEO Joins the Ranks of Bitcoin Skeptics: Is the Cryptocurrency a Real Threat to the US Dollar?”

Goldman Sachs CEO Dismisses Bitcoin as a Threat to USD The Rise of Bitcoin Bitcoin, the world’s first decentralized digital currency, has been making waves in the financial world since its inception in 2009. The cryptocurrency operates without a central authority or banks, and transactions take place directly between users without any intermediaries. With its…

Read More

Say Goodbye to Boring Heart Surgeries: Colibri’s TAVR Study Proves Pre-Packaged Valve is the Real MVP

Feeling Heart-y: Colibri Heart Valve Study Sheds Light on High-Risk TAVR Well folks, it looks like the world of cardiovascular research just got a little more exciting! The initial findings of Colibri Heart Valve’s multicenter high-risk TAVR EU pilot study were recently presented at PCR London Valves. And let me tell you, it’s got everyone…

Read More

Rev Up Your Ride: LeddarTech’s Latest ADAS Innovation, the LeddarNavigator, Takes the Stage at Autosens Europe 2024 with Ficosa by Its Side!

Joining Forces: LeddarTech® and Ficosa at Autosens Europe Quebec City, Canada, Sept. 18, 2024 (GLOBE NEWSWIRE) LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVision™, for ADAS, AD and parking applications, is pleased to join Ficosa Internacional SA (“Ficosa”), a top-tier…

Read More